T1 PERTURBED TRANSFORMING GROWTH FACTOR β SIGNALLING IN FIBROBLASTS INCREASES THE SUSCEPTIBILITY OF ALVEOLAR EPITHELIAL CELLS TO INJURY IN A NOVEL MOUSE MODEL OF SYSTEMIC SCLEROSIS
T2 HAPLOTYPE ANALYSIS AND FUNCTIONAL STUDIES REVEAL A ROLE FOR F2R (PAR1) POLYMORPHISMS IN SARCOIDOSIS
T3 OSTEOPONTIN IS EXPRESSED IN HUMAN PERIPHERAL BLOOD EOSINOPHILS AND CONTRIBUTES TO THEIR PRO-ANGIOGENIC ACTIVITY
T4 ENDOSTATIN: THE LINK BETWEEN ABERRANT ANGIOGENESIS AND DYSREGULATED EPITHELIAL REPAIR IN IDIOPATHIC PULMONARY FIBROSIS
T5 NEW TUBERCULOSIS VACCINES CAN DIMINISH AS WELL AS ENHANCE BCG INDUCED PROTECTION: RESULTS FROM A MURINE MODEL
T6 COGNITIVE DEFICITS IN PATIENTS WITH MODERATE TO SEVERE OBSTRUCTIVE SLEEP APNOEA
S001 SUBSTANTIAL INCREASE IN TUBERCULOSIS INCIDENCE IN ENGLAND AND WALES IN 2005
S002 CLINICAL PRESENTATION OF PULMONARY TUBERCULOSIS WITH AND WITHOUT HIV CO-INFECTION
S003 TUBERCULOSIS IN HEALTHCARE WORKERS IN NORTH EAST LONDON
S004 THE INCIDENCE OF TUBERCULOSIS IN RELATION TO DISTANCE FROM A DIAGNOSTIC AND TREATMENT CENTRE. A STUDY IN RURAL ZIMBABWE
S005 OUTCOMES OF NEW IMMIGRANT SCREENING FOR TUBERCULOSIS: IMPLICATIONS FOR IMPLEMENTATION OF NICE GUIDELINES
S006 EVIDENCE OF INCREASED GASTRIC ASPIRATION IN ACUTE LUNG ALLOGRAFT REJECTION
S007 THE EFFECT OF IMMUNOSUPPRESSANTS ON SECRETORY LEUCOPROTEINASE INHIBITOR PRODUCTION BY LUNG EPITHELIUM IN THE PRESENCE OF TRANSFORMING GROWTH FACTOR-BETA
S008 COMPARISON OF GLUCOCORTICOID SENSITIVITY IN LUNG ALVEOLAR MACROPHAGES AND PERIPHERAL BLOOD MONOCYTES FROM CLINICALLY STABLE LUNG TRANSPLANT RECIPIENTS
S009 IS THERE A ROLE FOR NATURAL KILLER CELLS FOLLOWING LUNG TRANSPLANTATION?
S010 FACTORS AFFECTING SUITABILITY OF PATIENTS FOR LUNG TRANSPLANTATION ASESSMENT IN A COHORT REFERRED TO A SINGLE CENTRE 2000–05
S011 PULMONARY VASCULAR REACTIVITY IN INFECTED SINGLE LUNG ALLOGRAFTS
S012 SURVEY OF RESPIRATORY UNITS IN THE UK: PLANNING FOR THE NATIONAL COPD RESOURCES AND OUTCOMES PROJECT
S013 PATIENT VIEWS ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE SERVICES: A FOCUS GROUP STUDY
S014 TREATMENT RECOMMENDATIONS FROM THE RESPIRATORY CLINIC: WHY ARE THEY NOT EFFECTED?
S015 ARE EVALUATED RESPIRATORY SERVICE DEVELOPMENTS IMPLEMENTED INTO CLINICAL PRACTICE?
S016 ESTABLISHMENT OF A COMMUNITY RESPIRATORY ASSESSMENT UNIT
S017 PICTURE ARCHIVING AND COMMUNICATIONS SYSTEM: NATIONAL SURVEY OF ITS AVAILABILITY, IMPLEMENTATION, AND ACCEPTABILITY AMONG RESPIRATORY SPECIALISTS IN THE UK, 2006
S018 PRIMARY AIRWAY FIBROBLASTS IN THE UNDERSTANDING OF ASTHMA: EXTRACELLULAR MATRIX GENE EXPRESSION
S019 INTERLEUKIN-13 EXPRESSION BY MAST CELLS IN THE AIRWAY SMOOTH MUSCLE BUNDLE IN EOSINOPHILIC BUT NOT NON-EOSINOPHILIC ASTHMA
S020 THE INDUCTION OF ANTIVIRAL RESPONSES IN HUMAN AIRWAY SMOOTH MUSCLE AND EPITHELIAL CELLS
S021 ACTIVATION OF NEUTROPHILS BY THE REPAIRING BRONCHIAL EPITHELIUM ARE REGULATED VIA PI3-KINASE/AKT/PROTEIN KINASE C DELTA-MEDIATED SIGNALS
S022 VASCULAR REMODELLING IS A FEATURE OF ASTHMA AND NON-ASTHMATIC EOSINOPHILIC BRONCHITIS
S023 CHARACTERISATION OF BONE MORPHOGENETIC PROTEIN AND TGF-β SIGNALLING PATHWAYS IN MONOCROTALINE AND HYPOXIA-INDUCED PULMONARY ARTERIAL HYPERTENSION IN THE RAT
S024 ANALYSIS OF THE HHT3 LOCUS ON CHROMOSOME 5, ENCODING A NEW GENE FOR HEREDITARY HAEMORRHAGIC TELANGIECTASIA
S025 ACTIVATION OF PROTEINASE ACTIVATED RECEPTOR-1 ON MESOTHELIAL CELLS INDUCES ACTIVATION OF TRANSFORMING GROWTH FACTOR-BETA VIA UPREGULATION OF THROMBOSPONDIN-1
S026 FALIURE OF BONE MORPHOGENETIC PROTEIN RECEPTOR TRAFFICKING IN PULMONARY ARTERIAL HYPERTENSION: POTENTIAL FOR RESCUE?
S027 EPITHELIAL MESENCYMAL TRANSITION OCCURS IN PRIMARY AIRWAY EPITHELIAL CELLS IN RESPONSE TO TRANSFORMING GROWTH FACTOR-BETA AND EPIDERMAL GROWTH FACTOR
S028 TALC INDUCES RELEASE OF TRANSFORMING GROWTH FACTOR-BETA FROM MESOTHELIAL CELLS IN VITRO AND SEROSAL ADHESION FORMATION IN VIVO
S029 THE IMPACT OF A LEGISLATIVE BAN ON SMOKING IN PUBLIC PLACES ON THE QUALITY OF HEALTH, PULMONARY FUNCTION, AND INFLAMMATION OF BAR-WORKERS IN SCOTLAND
S030 C-REACTIVE PROTEIN AND LUNG FUNCTION IN MIDDLE-AGED MEN IN NORTHERN IRELAND
S031 INCREASED CIRCULATING IL-6 AFTER WHOLE BODY AND INSPIRATORY MUSCLE EXERCISE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
S032 THE EFFECTS OF CANNABIS ON PULMONARY STRUCTURE, FUNCTION AND SYMPTOMS
S033 SERUM GAMMA-GLUTAMYL TRANSFERASE IN LUNG DISEASE
S034 OXIDATIVE STRESS INDUCES EPITHELIAL TO MESENCHYMAL TRANSITION IN BRONCHIAL EPITHELIAL CELLS: A POSSIBLE ROLE IN AIRWAY REMODELLING
S035 THE ROLE OF TRANSBRONCHIAL NEEDLE ASPIRATION IN AN INTEGRATED CARE PATHWAY FOR ASSESSMENT OF PATIENTS WITH SUSPECTED LUNG CANCER
S036 STENTING IN SUPERIOR VENA CAVAL OBSTRUCTION: A FIVE YEAR EXPERIENCE WITH LUNG CANCER
S037 A COMPARISON OF AUTOFLUORESCENCE BRONCHOSCOPY AND VIDEOBRONCHOSCOPY FOR THE DETECTION OF PRE-INVASIVE LESIONS IN PATIENTS WITH POSSIBLE LUNG CANCER
S038 IMPROVING THE DIAGNOSTIC YIELD FROM BRONCHOSCOPY WHERE THERE IS NO VISIBLE ENDOBRONCHIAL LESION
S039 MINIMISING INTERVENTIONS IN THE DIAGNOSIS AND STAGING OF LUNG CANCER THROUGH BIOPSY OF METASTASES AND MEDIASTINAL NODES AS AN INITIAL PROCEDURE
S040 CONGENITAL HEART DISEASE AND OTHER HETEROTAXIC DEFECTS IN A LARGE COHORT OF PATIENTS WITH PRIMARY CILIARY DYSKINESIA
S041 TRENDS IN PNEUMONIA AND EMPYEMA IN SCOTTISH CHILDREN IN THE PAST 25 YEARS
S042 DO ESTIMATIONS OF HABITUAL ACTIVITY IN CHILDREN WITH CYSTIC FIBROSIS PREDICT AEROBIC FITNESS?
S043 SMAD SIGNALLING AND MAP KINASE ACTIVITY IN EXPERIMENTAL CONGENITAL DIAPHRAGMATIC HERNIA
S044 THE ROLES OF ANGOIPOIETIN-1 AND TIE-2 IN LUNG ADAPTION AT BIRTH AND PULMONARY HYPERTENSION IN CONGENITAL DIAPHRAGMATIC HERNIA
S045 NATIONAL SURVEY OF CHILDREN WITH POST-INFECTIOUS OBLITERATIVE BRONCHIOLITIS: A PROGRESS REPORT
S046 IS FEV1 DECLINE SLOWER IN WORKERS WITH OCCUPATIONAL ASTHMA WITH NORMAL EXHALED NO?
S047 BAKERS’ KNOWLEDGE OF THE HEALTH RISKS POSED BY FLOUR DUST IN RELATION TO WORK RELATED RESPIRATORY SYMPTOMS
S048 ASTHMA AMONG SCOTTISH FARMERS MAY BE DETERMINED MORE BY OCCUPATIONAL RATHER THAN COMMON ALLERGENS
S049 OCCUPATIONAL ASTHMA CAUSED BY ARABIDOPSIS THALIANA
S050 SODIUM METABISULPHITE INDUCED AIRWAYS OBSTRUCTION IN WORKERS IN THE FISH PROCESSING INDUSTRY
S051 PREVALENCE OF ASTHMA RELATED TO EMPLOYMENT IN THE UK: A NATIONAL SURVEY THROUGH GENERAL PRACTICE
S052 INTERACTION BETWEEN SMAD AND MITOGEN-ACTIVATED PROTEIN KINASE SIGNALLING IN FAMILIAL PULMONARY ARTERIAL HYPERTENSION
S053 ACETYLATION OF HISTONE H4 AT NF-κB SITES ON PRE-PRO ET-1 PROMOTER IS INVOLVED IN SYNERGISTIC SYNTHESIS OF ET-1 IN HUMAN PULMONARY ARTERY SMOOTH MUSCLE CELLS TREATED WITH TNF-α AND IFN-γ
S054 FLUVASTATIN SELECTIVELY INHIBITS HYPOXIC PROLIFERATION AND ACTIVATION OF P38 MAP KINASE IN PULMONARY ARTERY FIBROBLASTS: IMPLICATIONS FOR PULMONARY HYPERTENSION TREATMENT
S055 TRANSFORMING GROWTH FACTOR β1 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PULMONARY ARTERY SMOOTH MUSCLE CELLS
S056 BMPRII DYSFUNCTION IN PULMONARY ARTERY SMOOTH MUSCLE CELLS CAUSES ABNORMAL GROWTH RESPONSE TO TGF-β
S057 IMAGE ANALYSIS OF ELASTIN CHANGES IN PULMONARY VASCULAR REMODELLING IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE SHOWS LOSS OF MEDIAL FIBRE ORGANISATION
S058 CAN RESPIRATORY OUTREACH SERVICE INFLUENCE SMOKING CESSATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOLLOWING ACUTE EXACERBATION?
S059 CAN SMOKERS PASS SEAMLESSLY FROM A HOSPITAL BASED TO A COMMUNITY BASED SMOKING CESSATION SERVICE? A RANDOMISED CONTROLLED TRIAL
S060 SMOKING HISTORY AND CESSATION IN ACUTE MEDICAL ADMISSIONS: A FOLLOW UP STUDY
S061 SMOKERS ADMITTED TO HOSPITAL: ROLE OF JUNIOR DOCTORS, SMOKING CESSATION SERVICES, AND SMOKE-FREE HOSPITAL
S062 THE NHS STOP SMOKING SERVICES: HOSPITAL STAFF AWARENESS AND THE PATTERN OF REFERRAL TO THE LOCAL (BASILDON AND THURROCK) SERVICES
S063 KNOWLEDGE OF QUIT SMOKING SERVICES BY HOSPITAL PAEDIATRIC STAFF
S063A MOTIVATIONAL EFFECTS OF SPIROMETRY ON SMOKING CESSATION
S064 MICROBIOLOGY INVESTIGATIONS IN COMMUNITY ACQUIRED PNEUMONIA: WHAT IS AVAILABLE FROM ENGLAND AND WALES LABORATORIES?
S065 CLINICAL AND SPUTUM CHARACTERISTICS OF PATIENTS WITH BRONCHIECTASIS ATTENDING A LARGE UNIVERSITY TEACHING HOSPITAL
S066 STAPHYLOCOCCUS AUREUS IN WEGENER’S GRANULOMATOSIS: COLONISATION OR CAUSATION?
S067 C-REACTIVE PROTEIN IS AN INDEPENDENT MARKER PREDICTING SEVERITY IN COMMUNITY ACQUIRED PNEUMONIA
S068 NEUTROPHIL-MEDIATED IMMUNITY TO MYCOBACTERIUM TUBERCULOSIS INFECTION: ROLE OF LIPOCALIN 2
S069 CHILDHOOD WHEEZE, PEAK FLOW, AND THE OXFORD TRANSPORT STRATEGY
S070 INCIDENCE OF ADRENAL SUPPRESSION IN CHILDREN ON HIGH DOSE INHALED STEROIDS
S071 BODY MASS INDEX, PHYSICAL ACTIVITY, AND BELIEFS ABOUT EXERCISE IN CHILDREN WITH ASTHMA
S072 PARENTS CAN DISTINGUISH BETWEEN DIFFERENT CHARACTERISTICS OF WHEEZE AT TWO YEARS OF AGE AND THIS HAS IMPLICATIONS FOR ASTHMA OUTCOME AT FIVE YEARS OF AGE
S073 CHANGES IN EXHALED NITRIC OXIDE AFTER DEFINITE SYSTEMIC STEROIDS IN CHILDREN WITH DIFFICULT ASTHMA
S074 ADRENOCEPTOR GENOTYPE PREDISPOSES TO EXACERBATIONS IN YOUNG ASTHMATICS ON SALMETEROL
S075 CHARACTERISATION OF FREQUENT EXACERBATORS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING THE BODY MASS INDEX, AIRFLOW OBSTRUCTION, DYSPNOEA, AND EXERCISE CAPACITY (BODE) INDEX
S076 AN EXPERIMENTAL MODEL OF VIRUS INDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION
S077 QUANTITATIVE DETECTION OF S PNEUMONIAE, H INFLUENZAE, AND M CATARRHALIS IN SPUTUM SAMPLES FROM CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS BY REAL-TIME POLYMERASE CHAIN REACTION
S078 A PROSPECTIVE STUDY OF COMMUNITY ACQUIRED PNEUMONIA RELATED EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ITS IMPACT ON MORBIDITY AND MORTALITY
S079 SEASONALITY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE EMERGENCY ADMISSIONS TO HOSPITAL, AND PREDICTABILITY USING SURVEILLANCE FOR INFLUENZA-LIKE ILLNESS
S080 THE EFFECTS OF A NURSE-LED INTERMEDIATE CARE PACKAGE IN PATIENTS WHO HAVE BEEN HOSPITALISED FOR AN EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
S081 LESSONS LEARNT SO FAR FROM THE CURRENT FOLLOW UP OF THE TASMANIAN ASTHMA SURVEY: A LONGITUDINAL STUDY OF RESPIRATORY HEALTH FROM AGE 7 TO 44 YEARS
S082 EXPOSURE TO HOUSE DUST MITE ALLERGEN IS ASSOCIATED WITH AN INCREASE IN BRONCHIAL HYPERRESPONSIVENESS OVER FOUR YEARS IN ASTHMA
S083 ADIPOSITY ASSOCIATES WITH ASTHMA, IGE, AND EOTAXIN LEVELS
S084 CHANGES IN AIRWAY WALL GEOMETRY OF THE APICAL SEGMENTAL BRONCHUS IN NON-EOSINOPHILIC ASTHMA
S085 THE SIGNIFICANCE OF ACUTE EXERCISE INDUCED HYPERVENTIALTION IN PATIENTS WITH SEVERE ASTHMA
S086 REFRACTORY ASTHMA PHENOTYPES AND THE RESPONSE TO SPUTUM EOSINOPHIL DIRECTED THERAPY
S087 CANNABIS AND RESPIRATORY TRACT CANCER: A CASE-CONTROL STUDY
S088 SURVIVAL SPECTRUM OF RESECTED NEUROENDOCRINE TUMOURS OF LUNG: A SINGLE CENTRE EXPERIENCE
S089 NATIONAL LUNG CANCER AUDIT (LUCADA): HIGHLIGHTS FROM THE FIRST ANNUAL REPORT
S090 FACTORS CONTRIBUTING TO BREACHES IN THE “62 DAY WAIT” TARGET FOR LUNG CANCER IN THE THE MERSEYSIDE AND CHESHIRE CANCER NETWORK
S091 PEMETREXED BASED CHEMOTHERAPY FOR MALIGNANT MESOTHELIOMA; A RETROSPECTIVE ANALYSIS OF 100 CONSECUTIVELY TREATED PATIENTS
S092 SURVIVAL RATES FOR 705 HISTOLOGICALLY PROVEN NON-SMALL CELL LUNG CANCER DIAGNOSED BETWEEN NOVEMBER 1997 AND DECEMBER 2004 AND MANAGED BY A MULTIDISCIPLINARY TEAM
S093 CHARACTERISATION OF BACTERIAL DIVERSITY IN CYSTIC FIBROSIS SPUTUM
S094 OUTCOME OF BURKHOLDERIA CEPACIA COMPLEX PULMONARY INFECTION IN PATIENTS WITH CYSTIC FIBROSIS 1990–2004
S095 FIRST ISOLATION OF PSEUDOMONAS AERUGINOSA: FAILURE OF ERADICATION TREATMENT ASSOCIATED WITH A CLONAL STRAIN
S096 DEVELOPMENT OF SPUTUM CALPROTECTIN AS A BIOMARKER OF CYSTIC FIBROSIS LUNG DISEASE ACTIVITY: EVIDENCE FROM CROSS SECTIONAL AND LONGITUDINAL STUDIES
S097 ALTERATIONS IN BONE METABOLISM OCCUR AT TIMES OF INFECTIVE EXACERBATION IN ADULTS WITH CYSTIC FIBROSIS
S098 IN-PATIENT PULMONARY REHABILITATION DURING ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: IMMEDIATE EFFECTS ON HEALTH STATUS AND EXERCISE CAPACITY
S099 PRIMARY CARE BASED PULMONARY REHABILITATION PROGRAMMES ARE EFFECTIVE AND MEET RECOGNISED EVIDENCED OUTCOME MEASURES: AN OBSERVATIONAL REPORT
S100 FUNCTIONAL OUTCOME IN PULMONARY REHABILITATION USING THE CANADIAN OCCUPATIONAL PERFORMANCE MEASURE
S101 FACTORS AFFECTING COMPLETION OF PULMONARY REHABILITATION PROGRAMMES IN SOUTH EAST LONDON
S102 THE BRITISH LUNG FOUNDATION LUNG EXERCISE PILOT PROJECT: IS IT EFFECTIVE?
S103 AUTOANTIBODY PROFILE RATHER THAN EXTENT OF SKIN DISEASE PREDICTS SEVERITY OF PULMONARY FIBROSIS IN SYSTEMIC SCLEROSIS
S104 THE COAGULATION CASCADE IN FIBROTIC LUNG DISEASE PROGRESSION: LOCAL EXPRESSION OF FACTOR X IS INCREASED IN THE INJURED AND FIBROTIC LUNG
S105 T-BET EXPRESSION IN BRONCHOALVEOLAR LAVAGE CELLS FROM PATIENTS WITH SARCOIDOSIS
S106 TUMOUR NECROSIS FACTOR-ALPHA ACCENTUATES TRANSFORMING GROWTH FACTOR-BETA DRIVEN EPITHELIAL TO MESENCHYMAL TRANSITION IN LUNG EPITHELIAL CELLS
S107 DETERMINANTS OF BRONCHOALVEOLAR ALVAGE FLUID CHEMOTACTIC ACTICTIVTY IN WEGENER’S GRANULOMATOSIS: THE INTERDEPENDENCE OF IL-1 AND IL-8
S108 THE FREQUENCY OF OCCURRENCE OF CT FEATURES OF DIFFUSE PARENCHYMAL LUNG DISEASE IN SECONDARY CARE
S109 THE TORCH (TOWARDS A REVOLUTION IN COPD HEALTH) STUDY: SALMETEROL/FLUTICASONE PROPIONATE IMPROVES QUALITY ADJUSTED SURVIVAL OVER THREE YEARS
S110 HIGH FLOW OXYGEN, HYPEROXIA, HYPERCAPNIA, ACIDOSIS, AND DEATH IN PATIENTS WITH ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. DO THE DATA SUPPORT A CAUSAL LINK?
S111 FUNCTIONAL STATUS MEASUREMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: THE VALUE OF THE FUNCTIONAL STATUS DOMAIN OF THE CLINICAL COPD QUESTIONNAIRE
S112 A RANDOMISED STUDY OF TIOTROPIUM RESPIMAT SOFT MIST INHALER VERSUS IPRATROPIUM PMDI IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
S113 PREDICTING AND PLANNING END OF LIFE CARE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: MRC SCORE IS AN IMPORTANT MARKER
S114 DOES A NURSE-LED PALLIATIVE CARE SERVICE FOR CHRONIC LUNG DISEASE HAVE A POSITIVE IMPACT ON QUALITY OF LIFE AND PATIENT SATISFACTION?
S115 SPECIALIST TRAINING IN RESPIRATORY MEDICINE, HOW DO WE LEARN?
S116 BTS QUESTIONNAIRE SURVEY OF FLEXIBLE TRAINING AND ATTITUDES SURROUNDING FLEXIBLE TRAINING AND WORKING IN SPECIALIST REGISTRARS IN UK
S117 PLOTTING THE DECLINE IN UK BASED RESPIRATORY RESEARCH: AN INTERNET BASED ANALYSIS
S118 THE IMPACT OF EUROPEAN WORKING TIME DIRECTIVE UPON RESPIRATORY SPECIALIST REGISTAR TRAINING
S119 INTERESTS OF RESPIRATORY SPECIALIST REGISTRARS IN ASPECTS OF RESPIRATORY CRITICAL CARE
S120 RETINOIC ACID INDUCES ALVEOLAR REGENERATION IN THE ADULT MOUSE LUNG OF DIFFERENT OUTBRED MOUSE STRAINS
S121 SPUTUM METAL IONS ARE BIOMARKERS FOR SUPPURATIVE AND INFLAMMATORY LUNG DISEASE
S122 MURINE MESENCHYMAL STEM CELLS GENERATE OSTEOSARCOMA-LIKE LESIONS IN THE LUNG: IMPLICATIONS FOR STEM CELL THERAPY
S123 STEPWISE INCREMENTAL CHANGES IN ADAM33 EXPRESSION DURING MOUSE LUNG DEVELOPMENT
S124 IL-13 SIGNALING POLYMORPHISMS PREDICT ASTHMA AND ATOPY PHENOTYPES IN AN UNSELECTED POPULATION
S125 CHRONOLOGICAL EXPRESSION OF CILIATED BRONCHIAL EPITHELIM 1 IN MOUSE AND HUMAN PULMONARY DIFFERENTIATION
S126 THE EXTENT OF SURGERY FOR MALIGNANT MESOTHELIOMA IN PATIENTS OVER THE AGE OF 65: A THERAPEUTIC DILEMMA?
S127 EPIDEMIOLOGY OF SPONTANEOUS PNEUMOTHORAX: A HOSPITAL BASED STUDY
S128 BEDSIDE TRANSTHORACIC ULTRASONOGRAPY BY RESPIRATORY PHYSICIANS
S129 AN AUDIT OF SELDINGER INTERCOSTAL CHEST DRAIN COMPLICATIONS
S130 THE EFFECT OF BLIND PERCUTANEOUS PLEURAL BIOPSY ON SUBSEQUENT VIDEO ASSISTED THORACOSCOPY
S131 TUBERCULOSIS DRUG RELATED HEPATITIS IN PATIENTS TREATED WITH STANDARD RIFAMPICIN/ISONIAZID/PYRAZINAMIDE THERAPY OVER A 25 YEAR PERIOD
S132 COMPARISON OF TWO, TRIPLE-DRUG REGIMENS CONTAINING CLARITHROMYCIN OR CIPROFLOXACIN AND ASSESSMENT OF IMMUNOTHERAPY WITH M VACCAE IN THE TREATMENT OF LUNG DISEASES CAUSED BY M AVIUM-INTRACELLULARE-SCOFULACEUM (MAIS OR MAC), M MALMOENSE AND M XENOPI
S133 OUTCOME OF TUBERCULOSIS TREATMENT: BLACKBURN 1986–2005
S134 MANAGING MULTI-DRUG RESISTANT TUBERCULOSIS IN THE UK
S135 FACTORS CONTRIBUTING TO DELAY IN DIAGNOSIS AND TREATMENT OF TUBERCULOSIS
S136 APNOEIC THRESHOLD: A TRUE DETERMINANT OF CARDIORESPIRATORY CONTROL STABILITY OR A MARKER OF CHEMOREFLEX GAIN?
S137 CAN CARDIAC PACEMAKERS DIRECTLY CONTROL VENTILATION?
S138 COMPARISON OF THE NEP AND FOT TECHNIQUES FOR MEASURING FLOW LIMITATION IN SUBJECTS WITH STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
S139 EXERCISE VENTILATION IN DIFFUSE PLEURAL DISEASE
S140 FLIGHT ASSESSMENT IN PATIENTS WITH RESPIRATORY DISEASE: AGREEMENT BETWEEN HYPOXIC CHALLENGE TESTING AND PREDICTIVE EQUATIONS
S141 DIFFERENTIAL EFFECTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR ISOFORMS ON PRIMARY HUMAN LUNG MICROVASCULAR ENDOTHELIAL CELL PROLIFERATION
S142 HEME OXYGENASE-1 IS INDUCED IN HUMAN NEUTROPHILS FOLLOWING SURGERY REQUIRING CARDIOPULMONARY BYPASS
S143 PULMONARY FIBROSIS IS AN EARLY FEATURE OF ACUTE LUNG INJURY/ACUTE RESPIRATORY DISTRESS SYNDROME
S144 EXHALED BREATH CONDENSATE GLUCOSE LEVELS PREDICT ADVERSE OUTCOME IN ACUTE RESPIRATORY DISTRESS SYNDROME
S145 ALVEOLAR INFECTION SIGNIFICANTLY DRIVES CHEMOTAXIS BUT NOT THE INFLAMMATORY CELL INFILTRATE IN ACUTE RESPIRATORY DISTRESS SYNDROME
S146 MITOCHONDRIAL REACTIVE OXYGEN SPECIES ARE REQUIRED FOR MECHANICAL STRAIN-INDUCED INTERLEUKIN-8 PRODUCTION BY LUNG EPITHELIAL CELLS
S147 THE EFFECT OF SITE AND INSPIRATORY PRESSURE ON THE DELIVERY OF SUPPLEMENTAL OXYGEN THERAPY DURING NON-INVASIVE VENTILATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
S148 AUDIT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS WITH ACUTE TYPE II RESPIRATORY FAILURE: ARE WE GIVING THEM A CHANCE?
S149 THE OUTCOME OF HOME NON-INVASIVE POSITIVE PRESSURE VENTILATION IN PATIENTS AT THE LONDON CHEST HOSPITAL
S150 RESPIRATORY FUNCTION AND SURVIVAL IN MOTOR NEURONE DISEASE
S151 COMPARATIVE PULMONARY MECHANICS IN CHILDREN AND ADULTS WITH NEUROMUSCULAR DISEASE
S152 THE EFFECT OF CPAP ON INSULIN RESISTANCE AND HBA1C IN PEOPLE WITH OBSTRUCTIVE SLEEP APNOEA AND TYPE 2 DIABETES: A RANDOMISED CONTROLLED TRIAL
S153 CHANGES IN HEALTH STATUS AFTER A TRIAL OF CONTINUOUS POSITIVE AIRWAY PRESSURE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA: 2 WEEK V 4 WEEK TRIAL
S154 CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA: CLINICAL UTILITY OF THE JOINT BRITISH SOCIETIES CARDIAC RISK ASSESSOR PROGRAM
S155 HIGH PREVALENCE OF SLEEP APNOEA AND NOCTURNAL HYPOVENTILATION IN PATIENTS ASSESSED FOR BARIATRIC SURGERY
S156 SNORING, SLEEPINESS, AND BEHAVIOURAL CORRELATES IN CHILDREN AND ADULTS WITH DOWN’S SYNDROME
P001 DELAY IN LUNG CANCER CLINIC APPOINTMENT: AUDIT OF GP REFERRALS
P002 IMPACT OF A TWO-STOP CLINIC ON DIAGNOSTIC TIMES, TREATMENT DELAYS, AND TREATMENT INTENT IN PATIENTS REFERRED WITH SUSPECTED LUNG CANCER
P003 CHEST PHYSICIANS AND LUNG CANCER NURSE SPECIALISTS: WHO PREDICTS THE MULTIDISCIPLINARY TEAM DISCUSSION OUTCOME BEST?
P004 BODY COMPOSITION ASSESSMENT IN PATIENTS ATTENDING A RAPID ACCESS LUNG CANCER CLINIC
P005 EFFECT OF RAPID ACCESS CLINICS ON STAFF: COMPARISON WITH OTHER DUTIES
P006 THE LUNG CANCER MDT: WHO CONTRIBUTES TO DECISION MAKING?
P007 COMPARING CANCER REGISTRY DATA WITH LOCAL LUCADA DATA
P008 ESTABLISHMENT AND EXPERIENCE OF A NURSE-LED HAEMOPTYSIS CLINIC
P009 NATIONAL LUNG CANCER AUDIT: DATA COMPLETENESS
P010 ARE WE GOING TO BE ABLE TO MEET THE “31 DAYS TO TREAT FROM REFERRAL” TARGET FOR LUNG CANCER PATIENTS?
P011 INCIDENCE OF LUNG CANCER IN PATIENTS RE-PRESENTING TO THE RAPID ACCESS LUNG CANCER CLINIC
P012 MANAGEMENT OF LUNG CANCER IN THE ELDERLY
P013 SURVIVAL FOLLOWING SURGICAL RESECTION OF LUNG CANCER: A DISTRICT EXPERIENCE
P014 PRIMARY THROMBOPROPHYLAXIS IN MEDICAL INPATIENTS: AN AUDIT OF OUR CURRENT PRACTICE WITHIN THE DIVISION OF MEDICINE OF A LARGE TEACHING HOSPITAL AND A POSSIBLE SOLUTION FOR CHANGE OF PRACTICE
P015 SEATED IMMOBILITY AT WORK IS A COMMON RISK FACTOR FOR VENOUS THROMBOEMBOLISM
P016 PULMONARY EMBOLI AND DEEP VENOUS THROMBOSES: PRECIPITATING FACTORS AND RISKS IN PATIENTS WITH HEREDITARY HAEMORRHAGIC TELANGIECTASIA AND PULMONARY ARTERIOVENOUS MALFORMATIONS
P017 THE USE OF IMAGING IN THE DIAGNOSIS AND EXCLUSION OF PULMONARY EMBOLISM: DO THE BTS GUIDELINES REDUCE THE NEED FOR IMAGING?
P018 THE PATH AFTER V/Q SCANNING IN A SUSPECTED PULMONARY EMBOLISM
P019 V/Q OR CTPA AS INVESTIGATION FOR PULMONARY EMBOLUS: AN AUDIT
P020 AUDIT: THE OUTPATIENT MANGEMENT OF CTPA CONFIRMED PULMONARY EMBOLIC DISEASE
P021 MICROTHROMBI IN A SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENT COHORT: A PILOT HISTOLOGICAL STUDY
P022 ISCHAEMIC STROKE AND BRAIN ABSCESS DUE TO PULMONARY ARTERIOVENOUS MALFORMATIONS
P023 PULMONARY ARTERIAL PRESSURE, PULMONARY ARTERIOVENOUS MALFORMATIONS (PAVMS), AND PAVM EMBOLISATION
P024 LONG TERM ADMINISTRATION OF INTRAVENOUS (IV) ILOPROST FOR PULMONARY ARTERIAL HYPERTENSION
P025 PHOSPHODIESTERASE TYPE 5 INHIBITOR AND THE SPECTRUM OF PULMONARY HYPERTENSION
P026 A POTENTIAL ROLE FOR SILDENAFIL IN THE MANAGEMENT OF PULMONARY HYPERTENSION IN PATIENTS WITH PARENCHYMAL LUNG DISEASE
P027 ACUTE HAEMODYNAMIC RESPONSES TO INHALED NITRIC OXIDE AND INTRAVENOUS SILDENAFIL IN DISTAL CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
P028 PULMONARY ARTERIAL PULSE PRESSURE AND MORTALITY IN PULMONARY ARTERIAL HYPERTENSION
P029 A ROLLING PROGRAMME FOR PULMONARY REHABILITATION: VIABLE OR NOT?
P030 EDUCATION IN PULMONARY REHABILITATION: THE PATIENTS’ PERSPECTIVE
P031 BRISTOL COPD KNOWLEDGE QUESTIONNAIRE: EXPERIENCE WITH 100 PATIENTS ATTENDING AN OUTPATIENT PULMONARY REHABILITATION PROGRAM
P032 A PILOT STUDY TO COMPARE QIGONG EXERCISES WITH CONVENTIONAL EXERCISES IN PULMONARY REHABILITATION
P033 IS A PRACTICE INCREMENTAL SHUTTLE WALK TEST REALLY NECESSARY?
P034 COMPARING THE INCREMENTAL SHUTTLE WALK TEST AND ENDURANCE SHUTTLE WALK TEST AS AN OUTCOME MEASURE FOR PULMONARY REHABILITATION
P035 USE OF THE MODIFIED CANADIAN OCCUPATIONAL PERFORMANCE MEASURE IN PULMONARY REHABILITATION
P036 INFLUENCE OF PULMONARY REHABILITATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON USE OF SECONDARY CARE RESOURCES
P037 POST-TRAUMATIC STRESS DISORDER AND CHRONIC LUNG DISEASE: PREVALENCE AND CHANGES FOLLOWING PULMONARY REHABILITATION
P038 WHY DO PATIENTS DECLINE TO TAKE PART IN A RESEARCH PROJECT INVOLVING PULMONARY REHABILITATION?
P039 BENCH-MARKING PULMONARY REHABILITATION: SHOULD THERE BE SOME STANDARDISATION?
P040 BEST BUY FOR PULMONARY REHABILITATION: COMPARISON OF COMMUNITY AND HOSPITAL PROVISION. A REPORT OF THE COHORT STUDY OF PULMONARY REHABILITATION
P041 CAN PATIENT VERBAL RATINGS OF BREATHLESSNESS FACILITATE RAPID CLINICAL ASSESSMENTS?
P042 RESPIRATORY FUNCTION IN THE ARCTIC: INVESTIGATION OF RESPIRATORY ACCLIMATISATION AND THE ROLE OF THE HPA AXIS
P043 IS THE USE OF EARLOBE CAPILLARY BLOOD SAMPLES FOR ASSESSMENT OF BLOOD GAS TENSIONS SUFFICIENTLY RELIABLE TO ALLOW ITS USE IN ROUTINE CLINICAL PRACTICE?
P044 CARDIOPULMONARY EXERCISE TESTING IN THE INVESTIGATION OF UNEXPLAINED BREATHLESSNESS
P045 CORRELATION OF THE TIMED WALK TEST WITH LUNG FUNCTION IN IDIOPATHIC PULMONARY FIBROSIS
P046 CAN RESPIRATORY PATIENTS ACCURATELY ESTIMATE THEIR EXERCISE TOLERANCE?
P047 RADIOLOGICAL AND CLINICAL FEATURES OF ALPHA-1-ANTITRYPSIN DEFICIENCY PATIENTS WITH DISCORDANT LUNG FUNCTION
P048 THE UTILITY OF OUTREACH LUNG BIOPSIES IN PERIPHERAL INTENSIVE CARE UNITS BY THORACIC SURGEONS FOR PATIENTS WITH RESPIRATORY FAILURE: A PRELIMINARY REPORT
P049 ORTHODEOXIA HINTS TOWARDS DIAGNOSIS OF ATRIAL SEPTAL DEFECTS AFTER PNEUMONECTOMY: REPORT OF THREE CASES AND A PROSPECTIVE STUDY
P050 SPREADING THE BENEFIT OF LUNG VOLUME REDUCTION SURGERY: ONE STAGE BILATERAL VERSUS A STAGED UNILATERAL APPROACH DETERMINED BY THE PATIENT
P051 DO EXPANDABLE METALLIC AIRWAY STENTS HAVE A ROLE IN THE MANAGEMENT OF PATIENTS WITH BENIGN TRACHEOBRONCHIAL DISEASE?
P052 MESOTHELIOMA AND RADICAL SURGERY: THE MARS TRIAL
P053 THE INTERRELATIONSHIP OF BODY MASS INDEX AND LUNG VOLUME REDUCTION SURGERY
P054 DOES THE WEIGHT OF LUNG RESECTED INFLUENCE THE OUTCOME OF LUNG VOLUME REDUCTION SURGERY?
P055 THE ABILITY OF SUBJECTS WITH CHEST INJURIES TO PROVIDE BREATH SAMPLES USING LION SL 400 BREATH ALCOHOL TESTING DEVICE: A STUDY USING POST-THORACIC SURGERY MODELS TO MIMIC CHEST INJURIES
P056 PRO AND ANTI-APOPTOTIC ACTIONS OF RESPIRATORY SYNCYTIAL VIRUS ON PRODUCTIVELY INFECTED DENDRITIC CELLS
P057 ITRACONAZOLE-MEDIATED INHIBITION OF CALCIUM ENTRY INTO CHEMOATTRACTANT-ACTIVATED HUMAN NEUTROPHILS IS DUE TO INTERFERENCE WITH PRODUCTION OF LEUKOTRIENE B4
P058 PATTERN OF AIRWAY INFLAMMATION IN ACUTE SEVERE ASTHMA
P059 PORTABLE EXHALED NITRIC OXIDE MEASUREMENT: COMPARISON WITH THE GOLD-STANDARD TECHNIQUE
P060 T CELL RECRUITMENT TO THE HUMAN ASTHMATIC AIRWAYS IS DEPENDENT ON CC CHEMOKINE RECEPTOR 4
P061 BRONCHOALVEOLAR LAVAGE AND FIBROBLAST ACTIVITY IN ASTHMA
P062 ST2 GENE KNOCKOUT ATTENUATES ALLERGIC AIRWAY INFLAMMATION
P063 THE CHEMOKINE RECEPTORS CCR8 AND CRTH2 ARE PREFERENTIALLY EXPRESSED ON PERIPHERAL BLOOD TH2 LYMPHOCYTES IN ASTHMA AND NORMAL SUBJECTS
P064 THE UNDERSTANDING AND COMPREHENSIBILITY OF PICTOGRAMS USED IN A NEW SCREENING TOOL FOR SLEEPINESS AND OBSTRUCTIVE SLEEP APNOEA SYNDROME
P065 PREVALENCE AND CLINICAL CHARCTERISTICS OF OBESITY HYPOVENTILATION SYNDROME PRESENTING TO A UK SLEEP CLINIC
P066 A DISTRICT GENERAL HOSPITAL SLEEP SERVICE BASED ON HOME OXIMETRY 1998–2006
P067 LONG TERM CHANGES IN QUALITY OF LIFE AND SLEEPINESS IN SNORERS AND SLEEP APNOEA PATIENTS
P068 VERY HIGH PREVALENCE OF SLEEP APNOEA SYMPTOMS IN PATIENTS WHO HAVE UNDERGONE ELECTIVE CARDIOVERSION FOR ATRIAL FIBRILLATION
P069 INVESTIGATING TIME WITH SIGNIFICANT NOCTURNAL DESATURATION AGAINST SLEEP APNOEA MARKERS POSSIBLY PREDICTING SLEEP RELATED PULMONARY HYPERTENSION
P070 INCORRECT DIAGNOSES OF TUBERCULOSIS USING LIQUID CULTURE MEDIUM: LESSONS TO BE LEARNT
P071 THE USE OF T-SPOT-TB TO ESTIMATE TB REACTIVITY RATES AMONG HEALTHCARE WORKERS ATTENDING THE BTS WINTER CONFERENCE 2005
P072 WHICH PATIENTS WITH TUBERCULOSIS ACCEPT AN HIV TEST?
P073 THE CLINICAL SPECTRUM OF ADULT TUBERCULOSIS: A UK PROSPECTIVE STUDY
P074 DIAGNOSTIC PATHWAYS IN CERVICAL TUBERCULOUS LYMPHADENITIS (CERVICAL TUBERCULOUS)
P075 DIRECT PCR EXAMINATION FOR MYCOBACTERIUM TUBERCULOSIS IN RESPIRATORY SAMPLES CAN BE COST EFFECTIVE
P076 THE PATIENT AT THE CENTRE OF THEIR CARE: AN IT BASED PACKAGE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PRIMARY CARE
P077 “VOLUME RESPONSE” TO BRONCHODILATORS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS RELATED BOTH TO FLOW LIMITATION AND EMPHYSEMA PHENOTYPE
P078 RELATION BETWEEN LUNG FUNCTION AND FRUIT CONSUMPTION IN SMOKING AND NON-SMOKING MEN IN NORTHERN IRELAND
P079 LUNG FUNCTION IN MID-LIFE IS A BETTER PREDICTOR OF ARTERIAL STIFFNESS THAN LATER LUNG FUNCTION: RESULTS FROM THE CAERPHILLY PROSPECTIVE STUDY
P080 CARDIOVASCULAR AND BONE DISEASE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P081 BONE THINNING: PREVALENT IN COPD BUT EARLY DETECTION ALLOWS TREATMENT OPPORTUNITY BEFORE VERTEBRAL FRACTURE OCCURS
P082 OUTDOOR ACTIVITY AND DEPRESSION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P083 EDUCATION FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS VARIABLE AND POORLY TARGETED: SELF-MANAGEMENT AND EXERCISE ARE NEGLECTED
P084 RANDOMISED CONTROLLED TRIAL OF NURSE-LED BREATHLESSNESS INTERVENTION TO IMPROVE THE MANAGEMENT OF BREATHLESSNESS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT A DISTRICT GENERAL HOSPITAL
P085 ICATS CHRONIC OBSTRUCTIVE PULMONARY DISEASE REFERRAL TRIAGE AND CLINIC OUTCOMES AUDIT
P086 VARIATION OF MOODS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND EFFECTS OF LONG TERM ANTIDEPRESSANTS TREATMENT ON MOODS
P087 DOES THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH PROVIDE AN APPROPRIATE MODEL FOR IDENTIFYING OUTCOME MEASURES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE?
P088 IMPACT OF THE FIRST NATIONAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE AUDIT ON A BUSY DISTRICT GENERAL HOSPITAL
P089 EVALUATION OF AN INNOVATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE CARE IN AN INNER LONDON HOSPITAL: RESULTS OF A QUALITATIVE STUDY
P090 AN EVALUATION OF RELATIONSHIPS BETWEEN FATIGUE AND DEPRESSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P091 AN OBSERVATIONAL STUDY OF PRESCRIBING FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PRIMARY CARE
P092 APPETITE CONTROLLING GUT HORMONE RELEASE DURING ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P093 CHEST RADIOGRAPH IN ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P094 DIFFERENCES BETWEEN SMOKERS AND EX-SMOKERS IN SEVERITY AND MECHANISMS OF INFECTIOUS EXACERBATIONS
P095 EXACERBATION FREQUENCY AND DECLINE IN FEV1 IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS WITH AND WITHOUT DIABETES
P096 PAYMENT BY RESULTS, THE TARIFF AND VIRTUAL EARLY SUPPORTED DISCHARGE
P097 ANXIETY AND DEPRESSION IN READMISSIONS TO HOSPITAL WITH ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P098 REDUCING CHRONIC OBSTRUCTIVE PULMONARY DISEASE WINTER ADMISSIONS BY PRE-EMPTIVE PATIENT REVIEW AND PROVISION OF EMERGENCY MEDICATIONS
P099 A QUESTIONNAIRE SURVEY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS WITH READMISSIONS AND PROLONGED LENGTH OF STAY
P100 THE EPIDEMIOLOGY OF SCOTTISH HOSPITAL ADMISSIONS DUE TO CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P101 FIRST NORTHERN IRELAND CHRONIC OBSTRUCTIVE PULMONARY DISORDER EARLY DISCHARGE SCHEME: A ONE YEAR REVIEW
P102 CHARACTERISTICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS ACCEPTED ONTO AN EARLY DISCHARGE SCHEME
P103 MANAGEMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE EMERGENCY DEPARTMENT: A COMPLETED AUDIT ON THE INTRODUCTION OF A PATHWAY
P104 SYMPTOMS AND EXACERBATIONS IN A CHRONIC OBSTRUCTIVE PULMONARY DISEASE POPULATION ASSESSED FOR EARLY DISCHARGE
P105 COUGH FREQUENCY DISTRIBUTION IN PATIENTS WITH CHRONIC COUGH USING AN AUTOMATED 24 HOUR AMBULATORY COUGH MONITOR
P106 OESOPHAGEAL IMPEDANCE-PH MONITORING IN GASTRO-OESOPHAGEAL REFLUX INDUCED COUGH
P107 BRONCHOSCOPIC ABNORMALITIES IN UNEXPLAINED CHRONIC COUGH
P108 CORRELATION BETWEEN AIRWAY WALL AREA OF THE APICAL SEGMENTAL BRONCHUS WITH DISTAL AIRWAY WALL THICKENING IN NON-ASTHMATIC EOSINOPHILIC BRONCHITIS
P109 WHAT IS THE MINIMAL IMPORTANT DIFFERENCE FOR THE LEICESTER COUGH QUESTIONNAIRE?
P110 IMPROVEMENT IN HEALTH STATUS FOLLOWING OUTPATIENT CHEST PHYSIOTHERAPY FOR PATIENTS WITH REFRACTORY CHRONIC COUGH
P111 THE TREATMENT OF CHRONIC COUGH WITH DISOFROL
P112 BACLOFEN IN COUGH SECONDARY TO GASTRO-OESOPHAGEAL REFLUX DISEASE
P113 TREATMENT OF CHRONIC COUGH WITH MORPHINE
P114 COMPUTERISED ANALYSIS OF COUGH SOUND CHARACTERISTICS IN DIFFERENT RESPIRATORY DISEASES
P115 DUST EXPOSURE AND RESTRICTIVE LUNG DISEASE IN CHILDREN IN KARAKALPAKSTAN, UZBEKISTAN
P116 AN INTERNATIONAL COLLABORATIVE INITIATIVE TO DEVELOP RELIABLE REFERENCE RANGES FOR PULMONARY FUNCTION IN YOUNG CHILDREN
P117 PAEDIATRIC PATIENT HAND HELD ASTHMA RECORDS
P118 POLYMICROBIAL INFECTION IN CYSTIC FIBROSIS INFANTS AT FIRST PRESENTATION
P119 THE PAEDIATRIC ADVANCED WARNING SCORE IN ACCIDENT AND EMERGENCY: VALIDATION OF A PHYSIOLOGY BASED “EARLY WARNING SCORE” FOR PAEDIATRIC ADMISSIONS
P120 SYSTEMATIC REVIEW OF THE COMMON THERAPIES IN CHRONIC NON-SPECIFIC COUGH IN CHILDHOOD
P121 TISSUE PLASMINOGEN ACTIVATOR FOR EMPYEMA IN CHILDREN
P122 AN AUDIT OF ORGANISMS ISOLATED FROM TRACHEAL SECRETIONS IN CHILDREN WITH TRACHEOSTOMIES ON LONG TERM VENTILATION
P123 OUTCOME OF WHEEZY INFANTS WITH ATOPIC BACKGROUND AT EARLY SCHOOL AGE: 5 YEAR FOLLOW UP TRIAL
P124 TWIN PEAKS: THE CHANGING EPIDEMIOLOGY OF COMPLICATED PNEUMONIA AND EMPYEMA IN CHILDREN
P125 RESPIRATORY MUSCLE PRESSURE MEASUREMENT IN CHILDREN WITH CYSTIC FIBROSIS
P126 ETHICAL PLANNING FOR AN INFLUENZA PANDEMIC
P127 MANAGEMENT OF COMMUNITY ACQUIRED PNEUMONIA: ARE WE FOLLOWING THE BTS 2004 CAP GUIDELINES UPDATE?
P128 POSITIVE MICROBIOLOGY IS MORE FREQUENT IN PATIENTS WITH SEVERE COMMUNITY ACQUIRED PNEUMONIA
P129 AN AUDIT OF THE USE OF NEBULISED 7% HYPERTONIC SALINE TO TREAT PATIENTS WITH BRONCHIECTASIS OR MUCUS HYPERSECRETION
P130 ANAEROBIC BACTERIA IN ADULT NON-CYSTIC FIBROSIS BRONCHIECTASIS
P131 IS SPUTUM LOAD A USEFUL OUTCOME MEASURE FOR CLINICAL TRIALS IN BRONCHIECTASIS?
P132 LYMPHOPENIA AND ITS RELATION TO FUNGAL INFECTION, LENGHT OF STAY, AND MORTALITY IN THE CRITICALLY ILL PATIENTS
P133 NECROTISING PNEUMONIA DUE TO PANTON-VALENTINE LEUKOCIDIN PRODUCING STAPHYLOCOCCUS AUREUS TREATED WITH INTRAVENOUS IMMUNOGLOBULIN
P134 A 12 MONTH REVIEW OF RESPIRATORY COMPLICATIONS OF HAEMATOLOGY INPATIENTS
P135 DOES VISUALISATION OF THE BRONCHIAL TREE ADD VALUE WHEN INVESTIGATING POSSIBLE LUNG INFECTION?
P136 DEVELOPMENT OF AN IN VITRO MODEL TO INVESTIGATE THE EFFECT OF GLUCOSE ON THE INTERACTION BETWEEN RESPIRATORY EPITHELIA AND BACTERIAL PATHOGENS
P137 ACQUISITION OF PENICILLIN RESISTANCE BY CELL WALL DEFECTIVE BACTERIA
P138 INTEROBSERVER VARIATION AND THE EFFECT OF EXPERIENCE IN THE DIAGNOSIS OF LUNG CANCER WITH A VIDEOBRONCHOSCOPE/AUTOFLUORESCENCE SYSTEM
P139 UTILITY OF ENDOBRONCHIAL ULTRASOUND (EBUS): A COMPARATIVE STUDY BETWEEN CONVENTIONAL TRANSBRONCHIAL NODAL ASPIRATION (TBNA) AND EBUS GUIDED TBNA
P140 EARLY EXPERIENCES OF TRANSBRONCHIAL NODE ASPIRATION IN THE DIAGNOSIS AND STAGING OF SUSPECTED LUNG CANCER AT WATFORD DISTRICT GENERAL HOSPITAL
P141 IS THERE A POTENTIAL FOR THE INCREASED USE OF TRANSBRONCHIAL NEEDLE ASPIRATION FOR CYTOLOGICAL DIAGNOSIS OF LUNG CANCER TO AVOID MORE INVASIVE TESTS? A UK DISTRICT GENERAL HOSPITAL EXPERIENCE
P142 CANCER YIELD OF PERSISTENT HAEMOPTYSIS AND ABNORMAL CHEST X RAYS NOT INDICATIVE OF MALIGNANCY
P143 HAEMOPTYSIS WITH A NORMAL CHEST RADIOGRAPH: A 5 YEAR FOLLOW UP AFTER A NORMAL BRONCHOSCOPY
P144 IDENTIFYING CLINICAL AND RADIOLOGICAL FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PNEUMOTHORAX COMPLICATING PERCUTANEOUS CT-GUIDED LUNG BIOPSY
P145 PREDICTING THE OCCURRENCE OF PULMONARY HAEMORRHAGE COMPLICATING PERCUTANEOUS CT-GUIDED LUNG BIOPSY: A STUDY OF CLINICAL AND RADIOLOGICAL VARIABLES
P146 PRELIMINARY EXPERIENCE USING LARGER CORE AUTOMATED NEEDLES FOR PERCUTANEOUS CT-GUIDED LUNG MASS BIOPSY: IS THERE ANY IMPROVEMENT IN DIAGNOSTIC ACCURACY AND COMPLICATION RATES?
P147 OUTCOME OF PATIENTS ATTENDING RAPID ACCESS LUNG CLINIC WHO UNDERGO CT THORAX BUT NO BRONCHOSCOPY
P148 TIMING OF COMPUTED TOMOGRAPHY AND BRONCHOSCOPY IN THE INVESTIGATION OF LUNG CANCER IN THE PENINSULA CANCER NETWORK
P149 USE OF PHRASES CONTAINED IN PET SCAN REPORTS TO HELP DIRECT PATIENT MANAGEMENT
P150 DOES THE USE OF PET IN THE STAGING PROCESS FOR NON-SMALL CELL LUNG CANCER SIGNIFICANTLY DELAY SURGICAL TREATMENT?
P151 AN EXPERIENCE OF PET SCANNING IN NON-SMALL CELL LUNG CANCER IN A TERTIARY CENTRE
P152 DO PET SCANS HELP REDUCE UNNECESSARY SURGERY FOR LUNG CANCER?
P153 GENDER DIFFERENCES IN THE RELATION BETWEEN LUNG FUNCTION AND C-REACTIVE PROTEIN IN THE ENGLISH LONGITUDINAL STUDY OF AGEING (ELSA)
P154 GENE EXPRESSION PROFILING OF THE EFFECTS OF CIGARETTE SMOKE ON MACROPHAGES
P155 HISTOLOGY OF THE DIFFUSE EPITHELIAL RESPONSE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PERIPHERAL LUNG SHOWS THAT MATURE TYPE II PNEUMOCYTES ARE NOT THE MAJOR COLONISING CELL
P156 INFLAMMATORY CELL INFILTRATION INTO PROXIMAL AIRWAY SMOOTH MUSCLE BUNDLES IN SUBJECTS WITH AND WITHOUT CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P157 MOLECULAR ANALYSIS OF BACTERIA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE SPUTUM SAMPLES
P158 RELATIONSHIP BETWEEN EXHALED NITRIC OXIDE AND EOSINOPHILIC AIRWAY INFLAMMATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P159 BRONCHOALVEOLAR LAVAGE OF SMOKERS HAVE INCREASED LYMPHOCYTE CHEMOKINE RECEPTOR EXPRESSION
P160 GRANULOCYTE TRAFFICKING IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P161 CIRCULATING MATRIX METALLOPROTEINASES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND BONE DISEASE
P162 COMPARISON OF METHODS FOR MULTIPLE FLOW RATE MODELLING OF EXHALED NITRIC OXIDE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P163 BRONCHOALVEOLAR LAVAGE OF SMOKERS HAVE INCREASED CD4 REGULATORY LYMPHOCYTES
P164 CONCEPTUAL AND PROPORTIONAL CLASSIFICATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PHENOTYPES
P165 COMPARISON OF REGIONAL VENTILATORY AND PERFUSION DEFECTS IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P166 ETHNIC DIFFERENCES IN SPIROMETRY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P166A HIGH SENSITIVITY C REACTIVE PROTEIN LEVELS CORRELATE WITH PULMONARY INFLAMMATION AND FEV1 IN STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P167 THE OUTCOME OF A REVIEW OF OXYGEN ORDERS FOLLOWING PATIENTS’ ATTENDANCE AT AN OXYGEN CLINIC
P168 EARLY EXPERIENCE OF A PHYSIOTHERAPY LED AMBULATORY OXYGEN CLINIC
P169 HIGH FLOW OXYGEN AS A RISK FACTOR FOR DEATH IN PATIENTS ADMITTED TO HOSPITAL WITH ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P170 ASSESSMENT FOR LONG TERM OXYGEN THERAPY AT A DISTRICT GENERAL HOSPITAL: DOES OVERNIGHT PACO2 PROVIDE ADDITIONAL INFORMATION?
P171 TOO MUCH OF A GOOD THING? OXYGEN ALERT CARDS ARE HELPFUL FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS AT RISK OF OXYGEN TOXICITY
P172 COMPARISON OF NON-INVASIVE MEASUREMENT OF PCO2 AND O2 SATURATION WITH ARTERIAL BLOOD GAS MEASUREMENT DURING ASSESSMENT FOR LONG TERM OXYGEN THERAPY
P173 REVIEW OF A FLIGHT ASSESSMENT SERVICE
P174 IS THE HOME OXYGEN ORDER FORM FIT FOR PURPOSE?
P175 REGIONAL DIFFERENCES IN AMBULATORY OXYGEN PROVISION IN THE UK
P176 DO WE NEED TO ADMIT PATIENTS OVERNIGHT FOR LONG TERM OXYGEN THERAPY ASSESSMENT?
P177 OXYGEN ASSESSMENT IN BLAENAU GWENT
P178 “DOOR TO MASK TIME” IN NON-INVASIVE VENTILATION FOR EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
P179 PREDICTORS OF OUTCOME FOR PATIENTS ADMITTED TO A RESPIRATORY HIGH CARE WARD
P180 OUTCOMES OF ACUTE NON-INVASIVE VENTILATION THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISORDER PATIENTS WITH A PH LESS THAN 7.25
P181 NON-INVASIVE VENTILATION: EVIDENCE OF EFFICACY AS MAXIMAL THERAPY IN ACUTE RESPIRATORY FAILURE OUTSIDE HDU/ICU
P182 CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS’ EXPERIENCE OF USING NON-INVASIVE VENTILATION AT HOME: A CASE STUDY APPROACH
P183 THE EFFECTS OF 1 WEEK’S WITHDRAWAL OF LONG TERM NON-INVASIVE VENTILATION IN HYPERCAPNIC CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
P184 MRSA: CROSS CONTAMINATION THROUGH USE OF NON-INVASIVE VENTILATION?
P185 A ONE YEAR RETROSPECTIVE REVIEW OF THE RADIOLOGICAL INVESTIGATIONS OF CONFIRMED MESOTHELIOMA PATIENTS IN A TERTIERY REFERAL CENTRE
P186 THE END OF THE LINE FOR ABRAMS PERCUTANEOUS PLEURAL BIOPSY? A SURVEY OF RESPIRATORY SPECIALIST REGISTRAR EXPERIENCE IN CLOSED PLEURAL BIOPSY
P187 ARE BLIND PERCUTANEOUS PLEURAL BIOPSIES STILL USEFUL IN THE DIAGNOSIS OF SUSPECTED MALIGNANT PLEURAL EFFUSIONS?
P188 NINETY TWO PER CENT OF CURRENT RESPIRATORY SPECIALIST REGISTRARS THINK THAT TRAINING IN CHEST ULTRASOUND EXAMINATION FOR PLEURAL DISEASES SHOULD BE INCLUDED IN THEIR TRAINING CURRICULUM: RESULTS OF A NATIONAL WEB-BASED QUESTIONNAIRE SURVEY ON THE PRACTICE OF CHEST ULTRASOUND EXAMINATION IN THE UK
P189 SURVEY OF THE PRACTICE OF CHEST ULTRASOUND EXAMINATION (FOR PLEURAL EFFUSIONS) AMONG CHEST PHYSICIANS IN THE UK
P190 CLINICAL CHARACTERISTICS AND OUTCOMES OF EMPYEMA THORACIS IN 117 PATIENTS: A COMPARATIVE ANALYSIS OF TUBERCULOUS VERSUS NON-TUBERCULOUS AETIOLOGIES
P191 THE MANAGEMENT OF SPONTANEOUS PNEUMOTHORAX: ARE WE ADHERING TO BRITISH THORACIC SOCIETY GUIDELINES?
P191A WHICH ASPECT OF CHEST DRAINAGE CAUSES MOST PAIN?
P192 ECONOMIC IMPLICATIONS OF NEWBORN SCREENING FOR CYSTIC FIBROSIS: REDUCED THERAPY MAY OFFSET SCREENING COSTS
P193 AN AUDIT OF THE NEW EFLOW®RAPID SYSTEM IN THE PAPWORTH ADULT CF UNIT
P194 THE EFFICACY, PREFERENCE, AND SAFETY OF A NOVEL METHOD OF SPUTUM CLEARANCE, HYDRO ACOUSTIC THERAPY, ON ADULT PATIENTS WITH CYSTIC FIBROSIS
P195 GLUCOCORTICOIDS AS AN ADJUVANT TREATMENT TO INTRAVENOUS ANTIBIOTICS FOR CYSTIC FIBROSIS PULMONARY EXACERBATIONS: A UK SURVEY
P196 BURKHOLDERIA SPECIES INFECTION AT THE MANCHESTER ADULT CYSTIC FIBROSIS CENTRE: CHANGING EPIDEMIOLOGY
P197 INFLUENZA VACCINATION IN CYSTIC FIBROSIS: ANY ROLE?
P198 ASSOCIATION BETWEEN ABNORMAL HEPATIC ENZYMES, FATTY CHANGE IN THE LIVER, AND ACUTE PULMONARY INFECTION IN CYSTIC FIBROSIS
P198A ADULT CYSTIC FIBROSIS LUNG FUNCTION, NUTRITION, AND SURVIVAL AT THE ROYAL BROMPTON HOSPITAL COMPARED WITH UK AND US DATA
P199 ALKYLPURINE-DNA GLYCOSYLASE AND ALKYLGUANINE-DNA ALKYLTRANSFERASE REPAIR ACTIVITY IN PERIPHERAL BLOOD MONONUCLEAR CELL NUCLEI FROM LUNG CANCER CASES AND CANCER FREE CONTROLS
P200 HUMAN SQUAMOUS CELL CARCINOMA CELL LINES CONTAIN A SELECTABLE SIDE POPULATION THAT IS CELL CYCLE DEPENDENT AND HAS CANCER STEM CELL-LIKE PROPERTIES
P201 CORRELATION BETWEEN THE THE EXPRESSION OF TOPOISOMERASE IIA AND THE THE INSTABILITY OF CHROMOSOME 17 IN THE INTRAOPERATIVE SPECIMENS IN NSCLC
P202 IL-13 MEDIATES PROINFLAMMATORY BUT NOT PROFIBROGENIC RESPONSES IN PRIMARY FIBROBLASTS
P203 TNFα ACCELERATES THE TGFβ-INDUCED “EPITHELIAL-MESENCHYMAL TRANSITION” IN LUNG EPITHELIAL CELLS
P204 PREMATURE SENESCENCE OF AIRWAY EPITHELIAL CELLS: A POSSIBLE ROLE IN AIRWAY REMODELLING AFTER HUMAN LUNG TRANSPLANTATION
P205 INVESTIGATION OF CLARA CELL 10 KDA PROTEIN (CC10) POSITIVE SQUAMOUS EPITHELIUM IN LPS-CHALLENGED RAT LUNG
P206 SHOTGUN PROTEOMIC ANALYSIS OF HUMAN INDUCED SPUTUM
P207 IS THE PREVALENCE OF ASTHMA DECLINING?
P208 INCREASED PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH AIRWAYS DISEASE: 10 YEARS’ EXPERIENCE IN A TEACHING HOSPITAL
P209 IS THERE A ROLE FOR INSPIRATORY FLOW RATE MEASUREMENTS PRIOR TO PRESCRIBING INHALED MEDICATIONS?
P210 EVIDENCE-BASED ASTHMA TRAINING IMPROVES ASTHMA MANAGEMENT SKILLS IN GENERAL PRACTICE: A COMMUNITY-BASED SURVEY
P211 THE EFFECTIVENESS OF SPEECH AND LANGUAGE THERAPY IN VOCAL CORD DYSFUNCTION
P212 SIMVASTATIN AS A POTENTIAL THERAPEUTIC ANTI-INFLAMMATORY AGENT IN ASTHMA
P213 THE RESPONSE TO METHOTREXATE IN REFRACTORY ASTHMA
P214 ELIGIBILITY FOR TREATMENT WITH OMALIZUMAB AMONG PATIENTS ATTENDING THE GLENFIELD HOSPITAL REFRACTORY ASTHMA CLINIC
P215 ASSOCIATION BETWEEN CONTROL OF ASTHMA AND GASTRO-OESOPHAGEAL REFLUX DISEASE SCORE
P216 SEVERE ASTHMA IS ASSOCIATED WITH TIDAL BREATHING CLOSE TO RESIDUAL VOLUME
P217 VALIDATION OF A MULTIDETECTOR CT SCANNER TO MEASURE PROXIMAL AND DISTAL AIRWAY WALL VOLUME
P218 THE NIJMEGEN QUESTIONNAIRE DOES NOT APPEAR TO PREDICT HYPERVENTILATION IN SUBJECTS WITH SEVERE ASTHMA
P219 ADIPOSITY PREDICTS ASTHMA AND PULMONARY FUNCTION IN A YOUNG ADULT POPULATION
P220 A MECHANISM WHEREBY A PROPENSITY TO WHEEZE MIGHT BOOST EXERCISE CAPACITY
P221 ADRENAL FUNCTION OF PATIENTS WITH BRONCHIECTASIS AND ASTHMA WHO TAKE INHALED CORTICOSTEROIDS
P222 INCREASES IN TUBERCULOSIS IN THE UK-BORN IN NORTH EAST LONDON AND THE LONDON BOROUGH OF HACKNEY
P223 THE PERSISTENT LINK BETWEEN TUBERCULOSIS AND POVERTY IN LIVERPOOL ILLUSTRATES THE INABILITY TO IMPROVE HEALTH INEQUALITIES IN ENGLAND
P224 INCIDENCE OF TUBERCULOSIS IN THE GREENWICH BOROUGH OF LONDON FROM 1993 TO 2005: AN OVERVIEW
P225 AN AUDIT OF PATIENTS WHO DIED WHILE ON TREATMENT FOR TUBERCULOSIS
P226 CHARACTERISTICS OF PATIENTS DYING WITH TUBERCULOSIS
P227 REVIEW OF ADVERSE EFFECTS AND TREATMENT ALTERATIONS IN 100 PATIENTS TREATED WITH ANTI-TUBERCULOSIS MEDICATION
P228 PATIENTS LOST TO TREATMENT FOR TUBERCULOSIS
P229 TREATMENT SUCCESS IN A COHORT OF PATIENTS WITH TUBERCULOSIS FROM AN INNER LONDON HOSPITAL. WHAT HAPPENED TO THE PATIENTS WHO TRANSFERRED OUT?
P230 CHARACTERISTICS OF PATIENTS NON-COMPLIANT WITH TUBERCULOSIS THERAPY IN LONDON